|
Zenith Corporate Update Slide Deck
|
3
|
Zenith Epigenetics
|
Dec 15, 2016 01:41PM
|
|
Re: What Did WE Learn Today
|
6
|
Resverlogix Corp.
|
Dec 15, 2016 05:34PM
|
|
Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 15, 2016 11:15PM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 10:26AM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 11:41AM
|
|
Re: A lot of expectations...???
|
2
|
Resverlogix Corp.
|
Dec 16, 2016 11:46AM
|
|
Re: AGM
|
2
|
Zenith Epigenetics
|
Dec 16, 2016 08:58PM
|
|
Re: AGM report again
|
4
|
Resverlogix Corp.
|
Dec 19, 2016 01:08PM
|
|
Re: Zenith AGM
|
3
|
Zenith Epigenetics
|
Dec 20, 2016 10:23AM
|
|
Zacks SCR Resverlogix Report 12/16/16
|
3
|
Resverlogix Corp.
|
Dec 20, 2016 10:34AM
|
|
Re: Zacks SCR Resverlogix Report 12/16/16
|
2
|
Resverlogix Corp.
|
Dec 20, 2016 10:44AM
|
|
Target modulation
|
8
|
Zenith Epigenetics
|
Dec 20, 2016 12:44PM
|
|
Angiochem's ANG1005 nearing start of Phase 3
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 21, 2016 03:45PM
|
|
Happy New Year from biOasis Technology inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 22, 2016 09:58AM
|
|
Re: Piper's 17 biopharma surprises for 17
|
7
|
Resverlogix Corp.
|
Dec 22, 2016 10:35AM
|
|
Re: Happy New Year from biOasis Technology inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 22, 2016 04:16PM
|
|
Enzalutamide/Abirate... Resistance and mCRPC
|
4
|
Zenith Epigenetics
|
Dec 22, 2016 04:48PM
|
|
Re: What does this mean
|
5
|
Zenith Epigenetics
|
Dec 23, 2016 08:12AM
|
|
Re: Longer wait = more successful;
|
5
|
Resverlogix Corp.
|
Jan 03, 2017 05:17PM
|
|
Re: Happy New Year from biOasis Technology inc.
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 05, 2017 10:08AM
|
